Seelos Therapeutics Inc (NASDAQ: SEEL) kicked off on November 17, 2023, at the price of $0.1239, up 1.36% from the previous trading day. During the day, the shares moved up to $0.131 and dropped to $0.1165 before settling in for the closing price of $0.12. Over the past 52 weeks, SEEL has traded in a range of $0.11-$1.66.
Annual sales at Healthcare sector company slipped by -20.00% over the past five years. While this was happening, its average annual earnings per share was recorded 51.28%. With a float of $157.88 million, this company’s outstanding shares have now reached $161.38 million.
Let’s look at the performance matrix of the company that is accounted for 16 employees.
Seelos Therapeutics Inc (SEEL) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Seelos Therapeutics Inc is 2.17%, while institutional ownership is 23.63%.
Seelos Therapeutics Inc (SEEL) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 9/29/2023, the organization reported -$0.12 earnings per share (EPS), lower than consensus estimate (set at -$0.06) by -$0.06. This company achieved a return on equity of -314.84. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 51.28% per share during the next fiscal year.
Seelos Therapeutics Inc (NASDAQ: SEEL) Trading Performance Indicators
Take a look at Seelos Therapeutics Inc’s (SEEL) current performance indicators. Last quarter, stock had a quick ratio of 0.18. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 13.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.45, a number that is poised to hit -0.12 in the next quarter and is forecasted to reach -0.31 in one year’s time.
Technical Analysis of Seelos Therapeutics Inc (SEEL)
Seelos Therapeutics Inc (NASDAQ: SEEL) saw its 5-day average volume 4.09 million, a positive change from its year-to-date volume of 2.01 million. As of the previous 9 days, the stock’s Stochastic %D was 22.65%. Additionally, its Average True Range was 0.02.
During the past 100 days, Seelos Therapeutics Inc’s (SEEL) raw stochastic average was set at 1.29%, which indicates a significant decrease from 23.95% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 89.19% in the past 14 days, which was lower than the 222.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.2873, while its 200-day Moving Average is $0.8047. Nevertheless, the first resistance level for the watch stands at $0.1328 in the near term. At $0.1392, the stock is likely to face the second major resistance level. The third major resistance level sits at $0.1473. If the price goes on to break the first support level at $0.1183, it is likely to go to the next support level at $0.1102. Assuming the price breaks the second support level, the third support level stands at $0.1038.
Seelos Therapeutics Inc (NASDAQ: SEEL) Key Stats
The company with the Market Capitalisation of 20.41 million has total of 127,891K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -73,530 K annual income. Company’s last quarter sales were recorded 340 K and last quarter income was -29,500 K.